Related Experiment Video
Updated: Mar 31, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
Phytochemicals with epigenetic properties and their role in melanoma therapy
Ioannis Anestopoulos1, Sotiris Kyriakou1, Maria V Deligiorgi2
1Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.
Abstract:
Malignant melanoma is the most aggressive and lethal type of skin cancer associated with increased mortality rates. Moreover, beyond the genetic background, the altered epigenetic landscape (e.g., abnormal patterns of DNA methylation, aberrant histone modifications and de-regulated expression levels of ncRNAs) further contributes to the pathophysiology of the disease. In addition, despite the improvement of current anti-melanoma strategies and the development of new therapeutic approaches, the 5-year survival among melanoma patients is still high, mainly due to acquired-drug resistance. On the other hand, phytochemicals have been associated with various health-promoting properties through pleiotropic mechanisms including acting as potent epigenetic regulators restoring back a normal phenotype in various experimental cancer models. In this review article, we discuss the general characteristics of malignant melanoma and current therapeutic approaches while we report the epigenetic basis of the disease along with the main compounds capable of restoring a normal epigenetic landscape. Finally, we describe the role of various phytochemicals in targeting the epigenome of malignant melanoma thereby potentially acting as an alternative therapeutic approach.
Insights
Phytochemicals show promise in combating malignant melanoma by targeting its epigenetic landscape. This review explores how these natural compounds can reverse epigenetic alterations and overcome drug resistance in skin cancer.
Area of Science:
- Oncology
- Epigenetics
- Pharmacology
Background:
- Malignant melanoma is an aggressive skin cancer with high mortality.
- Epigenetic alterations (DNA methylation, histone modifications, ncRNAs) drive melanoma.
- Acquired drug resistance limits current therapeutic efficacy.
Purpose of the Study:
- To review malignant melanoma characteristics and current treatments.
- To detail the epigenetic basis of melanoma.
- To explore phytochemicals as epigenetic modulators for melanoma.
Main Methods:
- Literature review of malignant melanoma pathophysiology.
- Analysis of epigenetic mechanisms in melanoma.
- Investigation of phytochemicals' role in epigenetic regulation.
Main Results:
- Phytochemicals exhibit pleiotropic effects and can act as epigenetic regulators.
- These compounds can restore normal cellular phenotypes in cancer models.
- Phytochemicals offer a potential strategy to target the melanoma epigenome.
Conclusions:
- Phytochemicals represent a promising avenue for alternative melanoma therapy.
- Targeting the epigenome with phytochemicals may overcome drug resistance.
- Further research into phytochemicals could lead to novel anti-melanoma treatments.
Related Concept Videos
Mitogens and the Cell Cycle
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Pigmentation
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
Abnormal Proliferation
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

